STERIS plc (NYSE:STE) Shares Acquired by Congress Wealth Management LLC DE

Congress Wealth Management LLC DE grew its stake in shares of STERIS plc (NYSE:STE) by 61.8% during the 1st quarter, Holdings Channel.com reports. The firm owned 115,916 shares of the medical equipment provider’s stock after acquiring an additional 44,288 shares during the period. Congress Wealth Management LLC DE’s holdings in STERIS were worth $26,060,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in STE. VisionPoint Advisory Group LLC bought a new position in shares of STERIS during the fourth quarter worth about $34,000. Pingora Partners LLC bought a new position in shares of STERIS in the fourth quarter worth about $37,000. Glassman Wealth Services acquired a new position in shares of STERIS in the fourth quarter valued at $38,000. Spire Wealth Management lifted its stake in STERIS by 88.0% during the fourth quarter. Spire Wealth Management now owns 203 shares of the medical equipment provider’s stock worth $45,000 after purchasing an additional 95 shares during the period. Finally, AdvisorNet Financial Inc grew its stake in STERIS by 144.9% during the fourth quarter. AdvisorNet Financial Inc now owns 311 shares of the medical equipment provider’s stock worth $68,000 after buying an additional 184 shares during the last quarter. 94.69% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the company. JMP Securities reissued a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research note on Thursday, May 9th. Needham & Company LLC reaffirmed a “hold” rating on shares of STERIS in a research note on Friday, May 10th. StockNews.com raised STERIS from a “hold” rating to a “buy” rating in a report on Saturday, June 15th. Finally, Piper Sandler restated a “neutral” rating and issued a $225.00 price objective (up previously from $220.00) on shares of STERIS in a research note on Friday, May 10th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, STERIS has a consensus rating of “Moderate Buy” and a consensus price target of $241.60.

STERIS Trading Down 0.5 %

Shares of STE stock traded down $1.00 during trading hours on Monday, hitting $218.54. 843,177 shares of the company were exchanged, compared to its average volume of 498,209. The firm has a market cap of $21.60 billion, a P/E ratio of 57.21 and a beta of 0.83. The company has a 50 day simple moving average of $220.44 and a two-hundred day simple moving average of $221.24. The company has a debt-to-equity ratio of 0.49, a quick ratio of 2.36 and a current ratio of 3.08. STERIS plc has a fifty-two week low of $195.47 and a fifty-two week high of $254.00.

STERIS (NYSE:STE) last posted its earnings results on Wednesday, May 8th. The medical equipment provider reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.41 by $0.17. STERIS had a net margin of 6.95% and a return on equity of 13.73%. The firm had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.41 billion. During the same quarter in the prior year, the business posted $2.30 EPS. The business’s revenue was up 10.8% compared to the same quarter last year. Equities analysts anticipate that STERIS plc will post 9.24 EPS for the current year.

STERIS Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, June 26th. Shareholders of record on Wednesday, June 12th were paid a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 0.95%. The ex-dividend date was Wednesday, June 12th. STERIS’s dividend payout ratio (DPR) is currently 54.45%.

Insider Buying and Selling

In other STERIS news, Director Jacqueline B. Kosecoff sold 4,584 shares of the stock in a transaction on Monday, May 13th. The stock was sold at an average price of $231.53, for a total value of $1,061,333.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other STERIS news, Director Jacqueline B. Kosecoff sold 4,584 shares of the firm’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $231.53, for a total transaction of $1,061,333.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Cary L. Majors sold 2,024 shares of the stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $232.13, for a total value of $469,831.12. Following the completion of the sale, the senior vice president now owns 11,369 shares in the company, valued at $2,639,085.97. The disclosure for this sale can be found here. Insiders have sold a total of 7,762 shares of company stock worth $1,798,477 in the last 90 days. 1.14% of the stock is owned by company insiders.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.